tradingkey.logo
tradingkey.logo
Search

Bionano Genomics Inc

BNGO
Add to Watchlist
1.070USD
+0.010+0.94%
Close 07-31 16:00ETQuotes delayed by 15 min
11.49MMarket Cap
LossP/E TTM

BNGO Financials

See Bionano Genomics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Bionano Genomics Inc Earnings Date

Latest Release
Aug 10, 2026
EPS / Forecast
--/-0.69
Revenue / Forecast
--/7.48M
Period
FY2025 Earnings
Revenue(YoY)
28.51M
-7.37%
EPS(YoY)
-4.85
99.91%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
34.32%-0.76
93.69%-0.77
94.85%-1.59
86.17%-1.99
96.78%-1.15
81.50%-12.22
83.98%-30.92
80.57%-14.40
51.53%-35.75
15.46%-66.06
---192.96
---74.12
---73.75
---78.15
---196.60
----
----
----
----
----
Revenue
3.56%6.69M
-2.60%7.95M
21.31%7.37M
-13.36%6.73M
-26.37%6.46M
-23.86%8.16M
-34.83%6.07M
-10.29%7.77M
18.26%8.77M
30.51%10.72M
29.04%9.32M
29.87%8.66M
30.18%7.42M
30.36%8.21M
55.12%7.22M
72.98%6.67M
79.80%5.70M
57.94%6.30M
111.98%4.66M
226.23%3.86M
Net Profit
-167.67%-8.30M
60.58%-7.93M
80.78%-8.50M
57.74%-6.86M
90.13%-3.10M
54.15%-20.13M
60.69%-44.25M
58.31%-16.22M
15.36%-31.42M
-13.48%-43.89M
-253.88%-112.57M
-21.00%-38.91M
-23.94%-37.12M
-68.53%-38.68M
-53.27%-31.81M
-71.18%-32.16M
-201.12%-29.95M
-95.64%-22.95M
-92.30%-20.75M
-132.67%-18.79M
Net Margin
-158.46%-124.17%
59.53%-99.77%
84.16%-115.42%
51.22%-101.84%
86.59%-48.04%
39.78%-246.54%
39.69%-728.57%
53.53%-208.78%
28.43%-358.33%
13.04%-409.39%
---1208.05%
---449.23%
---500.66%
---470.81%
---479.50%
----
----
----
----
----
Gross Margin
6.88%48.63%
2.13%42.75%
132.89%45.74%
55.24%51.64%
41.29%45.50%
84.08%41.86%
-571.41%-139.07%
24.84%33.26%
15.36%32.20%
3.50%22.74%
--29.50%
--26.65%
--27.92%
--21.97%
--21.14%
----
----
----
----
----
Debt to assets ratio
343.35%21.39%
275.96%18.63%
293.18%17.17%
589.97%20.43%
98.29%4.82%
175.44%4.96%
105.15%4.37%
106.92%2.96%
82.54%2.43%
41.69%1.80%
--2.13%
--1.43%
--1.33%
--1.27%
--1.21%
----
----
----
----
----
Revenue
3.56%6.69M
-2.60%7.95M
21.31%7.37M
-13.36%6.73M
-26.37%6.46M
-23.86%8.16M
-34.83%6.07M
-10.29%7.77M
18.26%8.77M
30.51%10.72M
29.04%9.32M
29.87%8.66M
30.18%7.42M
30.36%8.21M
55.12%7.22M
72.98%6.67M
79.80%5.70M
57.94%6.30M
111.98%4.66M
226.23%3.86M
Operating profit
6.71%-7.90M
27.68%-8.54M
62.27%-8.54M
50.64%-7.80M
68.05%-8.46M
52.70%-11.80M
37.03%-22.63M
59.73%-15.80M
30.00%-26.49M
30.16%-24.95M
-11.77%-35.93M
-22.32%-39.24M
-26.38%-37.84M
-30.95%-35.73M
-55.47%-32.15M
-94.70%-32.08M
-168.23%-29.94M
-154.36%-27.28M
-126.56%-20.68M
-121.60%-16.48M
Net Profit
-167.67%-8.30M
60.58%-7.93M
80.78%-8.50M
57.74%-6.86M
90.13%-3.10M
54.15%-20.13M
60.69%-44.25M
58.31%-16.22M
15.36%-31.42M
-13.48%-43.89M
-253.88%-112.57M
-21.00%-38.91M
-23.94%-37.12M
-68.53%-38.68M
-53.27%-31.81M
-71.18%-32.16M
-201.12%-29.95M
-95.64%-22.95M
-92.30%-20.75M
-132.67%-18.79M
Current assets
-13.25%38.98M
14.93%45.39M
3.87%48.80M
-29.56%42.66M
-47.52%44.93M
-71.82%39.49M
-55.06%46.98M
-50.59%60.57M
-39.95%85.61M
-10.92%140.12M
-52.09%104.54M
-43.33%122.58M
-41.18%142.56M
-42.26%157.30M
-36.21%218.20M
-36.75%216.29M
-34.54%242.36M
482.22%272.41M
1069.79%342.05M
1287.06%341.96M
Total current liabilities
-19.62%21.23M
-38.57%22.94M
-30.27%22.98M
-34.96%24.18M
-54.86%26.41M
-62.67%37.34M
-18.02%32.95M
10.97%37.17M
53.42%58.51M
178.75%100.03M
19.98%40.19M
20.03%33.50M
104.38%38.13M
64.30%35.88M
89.24%33.50M
160.09%27.91M
160.27%18.66M
144.16%21.84M
-28.57%17.70M
-45.00%10.73M
Total assets
-17.36%64.80M
-4.03%73.58M
-9.50%79.06M
-41.24%76.01M
-50.37%78.41M
-64.24%76.67M
-51.97%87.36M
-52.33%129.36M
-45.92%158.00M
-30.28%214.40M
-43.80%181.90M
-15.60%271.38M
-16.10%292.15M
-18.46%307.50M
-10.00%323.70M
-9.88%321.55M
-9.52%348.21M
523.82%377.10M
768.82%359.66M
1211.60%356.81M
Total liabilities
-9.54%27.34M
-29.39%29.16M
-23.98%29.26M
-37.51%30.64M
-59.82%30.23M
-65.08%41.30M
-38.81%38.49M
-13.42%49.03M
24.00%75.22M
103.51%118.25M
49.93%62.91M
53.80%56.63M
63.84%60.66M
45.33%58.10M
131.90%41.96M
236.45%36.82M
67.21%37.03M
57.61%39.98M
-32.29%18.09M
-48.79%10.94M
Total equity
-22.26%37.46M
25.58%44.42M
1.91%49.80M
-43.52%45.37M
-41.78%48.19M
-63.21%35.38M
-58.93%48.87M
-62.59%80.34M
-64.24%82.77M
-61.44%96.16M
-57.76%119.00M
-24.58%214.76M
-25.61%231.49M
-26.02%249.40M
-17.51%281.74M
-17.68%284.73M
-14.21%311.19M
860.94%337.12M
2227.37%341.56M
5825.41%345.87M
Net operating income
-106.80%-5.72M
35.81%-4.17M
55.53%-5.92M
83.38%-3.49M
90.17%-2.76M
78.16%-6.50M
49.38%-13.31M
42.83%-20.98M
13.21%-28.13M
13.73%-29.78M
10.79%-26.29M
-29.52%-36.70M
0.25%-32.41M
-34.72%-34.52M
-47.50%-29.47M
-128.13%-28.33M
-133.70%-32.49M
-111.68%-25.62M
-82.32%-19.98M
-72.06%-12.42M
Net investment
138.80%5.46M
33.77%4.01M
13.13%-4.67M
-93.09%1.98M
-129.56%-14.07M
105.41%3.00M
-116.08%-5.38M
-3.20%28.63M
187.91%47.59M
-576.94%-55.37M
320.31%33.43M
-5.33%29.58M
-48.29%16.53M
112.55%11.61M
104.28%7.95M
42116.22%31.24M
133283.33%31.96M
---92.51M
-7475.59%-185.60M
--74.00K
Net financing
-93.97%657.00K
-58.79%1.60M
67.35%10.08M
174.27%1.47M
150.38%10.89M
-94.32%3.89M
-52.17%6.02M
-111.06%-1.98M
-245.46%-21.62M
46806.85%68.48M
-44.43%12.59M
8708.37%17.88M
212214.29%14.86M
-92.58%146.00K
64.54%22.65M
101.18%203.00K
-100.00%7.00K
-93.79%1.97M
-8.73%13.77M
-205.47%-17.16M

FAQs

What is the total revenue of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its total revenue reached 28.51M, with a year-on-year change of 30.78M.

What are the current assets of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its current assets were 45.39M, with a year-on-year change of 14.93.

What are the total assets of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its total assets of Bionano Genomics Inc were 73.58M, with a year-on-year change of -4.03.

What are the total liabilities of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its total liabilities of Bionano Genomics Inc were 29.16M, with a year-on-year change of -29.39.

What is the total equity of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its total equity of Bionano Genomics Inc was 44.42M, with a year-on-year change of 25.58.

What is the net operating income of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its net operating income of Bionano Genomics Inc was -33.34M, with a year-on-year change of 56.29.

What is the net investment of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its net investment of Bionano Genomics Inc was -12.75M, with a year-on-year change of -117.26.

What is the net financing of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its net financing of Bionano Genomics Inc was 24.04M, with a year-on-year change of 275.66.

What is the Earnings Per Share (EPS) of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.85, with a year-on-year change of 99.91.

What is the net income of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its net income was -26.39M, with a year-on-year change of 76.44.

What is the net margin of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its net profit margin was -92.59, with a year-on-year change of 74.56.

What is the gross margin of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its gross margin was 27.31, with a year-on-year change of 235.12.

What is the debt-to-asset ratio of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its debt-to-asset ratio was 18.63, with a year-on-year change of -40.88.

What is the Return on Equity (ROE) of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its Return on Equity (ROE) was -66.15, with a year-on-year change of 61.16.

What is the Return on Assets (ROA) of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its Return on Assets (ROA) was -35.13, with a year-on-year change of 54.35.

What is the operating profit of Bionano Genomics Inc?

According to Bionano Genomics Inc's FY2025 earnings report, its operating profit was -33.34M, with a year-on-year change of 56.29.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.